Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pshah
    Junior Member
    • Sep 2015
    • 3

    #1

    htseq-count failure parsing GFF attribute line

    Hi,
    I am trying to generate a read counts file for my ChIP-seq data using htseq-count. Here is what I have done so far:

    1. Call ChIP-seq peaks and output BED file in MACS2
    2. Convert BED to GFF in Galaxy
    2. Run htseq-count with the following command and error:

    Code:
    -bash-4.1$ htseq-count -f bam -s no -t feature M1-cbx5_sorted.bam Rep1_cbx5_merge.gff
    Error occured when processing GFF file (line 1 of file Rep1_cbx5_merge.gff):
      Failure parsing GFF attribute line
      [Exception type: ValueError, raised in __init__.py:164]
    I suspect that there is something wrong with my GFF input, but I am not sure what.

    Here is what my GFF file looks like:
    Code:
    -bash-4.1$ head Rep1_cbx5_merge_edit.gff
    chr1	bed2gff	feature	823401	825999	0	+	.	group1;
    chr1	bed2gff	feature	927001	928999	0	+	.	group2;
    chr1	bed2gff	feature	1048201	1050799	0	+	.	group3;
    chr1	bed2gff	feature	1264401	1266799	0	+	.	group4;
    chr1	bed2gff	feature	2008801	2011399	0	+	.	group5;
    chr1	bed2gff	feature	2185201	2188399	0	+	.	group6;
    chr1	bed2gff	feature	2577201	2578999	0	+	.	group7;
    chr1	bed2gff	feature	2786201	2789199	0	+	.	group8;
    chr1	bed2gff	feature	2923401	2926199	0	+	.	group9;
    chr1	bed2gff	feature	3256401	3264399	0	+	.	group10;
    Thanks for helping me out!
  • Michael.Ante
    Senior Member
    • Oct 2011
    • 127

    #2
    Please have a look at the GFF format description (e.g. here). You need to rephrase the last column to ID=group1; ID=group2; ...

    Cheers,
    Michael

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    1 view
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Working...